Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

INVN vs. SHPAX: which is better?

Bottom line

INVN vs SHPAX: the short answer

INVN (Alger Russell Innovation ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.

INVN is cheaper at 0.55% vs 3% — a difference of $245 a year per $10,000 invested.

SHPAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

INVN vs SHPAX side by side

INVNSHPAX
TypeETFMutual fund
Fund familyAlgerSaratoga Advantage
CategoryTechnology SectorTechnology Sector
Expense ratio0.55%3%
Annual cost per $10k$55$300
10-yr cost on $10k (prospectus)$1,495$3,702
Max front loadNone5.75%
12b-1 fee0%—
1-yr return—−5.5%
5-yr return (annualized)—+3.1%
10-yr return (annualized)—+4.1%
Best quarter—+15.0%
Worst quarter—−13.0%
Net assets (fund)$9.6M$10.5M
Number of holdings5129
Portfolio turnover68%22%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

5 of INVN's top 25 holdings also appear in SHPAX's top 25.

Shared top holdings
HoldingINVNSHPAX
Merck & Company Inc2.12%3.63%
Incyte Corp2.11%2.89%
Bristol-myers Squibb Company2.03%3.07%
Regeneron Pharmaceuticals Inc2.03%3.93%
Exelixis Inc2.03%4.55%

Source: SEC Form N-PORT

INVN top 10

  1. Roblox Corp — 2.57%
  2. Zebra Technologies Corp — 2.38%
  3. Expedia Group Inc — 2.29%
  4. Maplebear Inc — 2.25%
  5. Block Inc — 2.24%
  6. Zscaler Inc — 2.22%
  7. Bill Holdings Inc — 2.19%
  8. Biogen Inc — 2.18%
  9. Ccc Intelligent Solutions Holdings Inc — 2.15%
  10. Etsy Inc — 2.15%

SHPAX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

FAQ

What is the difference between INVN and SHPAX?
INVN (Alger Russell Innovation ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 18% of their top holdings (by weight) are shared. INVN is cheaper at 0.55% vs 3% — a difference of $245 a year per $10,000 invested.
Which is cheaper, INVN or SHPAX?
INVN has the lower expense ratio (0.55%).
Should I own both INVN and SHPAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.